Temporal Trends in the Prescription of Biosimilars and the Status of Switching from Original Biologics to Biosimilars at Individual and Institutional Levels in Japan. [PDF]
Matsumoto M +11 more
europepmc +1 more source
RFX6 maturity-onset diabetes of the young: clinical considerations and novel use of tirzepatide. [PDF]
Gopalakrishnan PP +6 more
europepmc +1 more source
Cardiovascular Risk Reduction With Tirzepatide, a Dual GIP/GLP-1 Agonist, in Patients With Type 2 Diabetes Mellitus. [PDF]
Terui S +3 more
europepmc +1 more source
Uncontrolled diabetes may cause a transient decrease in ovarian reserve parameters to a suboptimal level: Recovery with optimized glycemic control - A case report. [PDF]
Campbell MA, Dahan MH.
europepmc +1 more source
Bilateral acquired chorea: a unique presentation of diabetic ketoacidosis. [PDF]
Wilson ZSC, Samudrala S, Tsai A.
europepmc +1 more source
Personalized management of glucokinase-related monogenic diabetes (GCK-MODY) during pregnancy: a case report. [PDF]
Bolas AF +3 more
europepmc +1 more source
Autologous Blood Injection: A Simple and Promising Treatment for Insulin-Induced Lipoatrophy with Wider Therapeutic Applications. [PDF]
Atılan AU, Bolel B, Turan Ç.
europepmc +1 more source
Nano-Amounts of Glucagon Premixed With Fast-Acting Insulin Lispro: Effect on Insulin Absorption in Pigs. [PDF]
Dirnena-Fusini I +3 more
europepmc +1 more source
Basal-bolus regimen versus twice-daily premixed insulin in the treatment of childhood type 1 diabetes mellitus in Mosul City: A comparison study. [PDF]
Mohialdeen IA, Al-Numan AH.
europepmc +1 more source
Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Injections for Glycemic Control in Pediatric Patients With Type 1 Diabetes Mellitus: A Systematic Review, Meta-Analysis, and Trial Sequential Analysis. [PDF]
Calderon Martinez E +11 more
europepmc +1 more source

